Document is current
Any future updates will be listed below
-
Authors
Biswas, Dhruva https://orcid.org/0000-0001-9141-5188
Liu, Yun-Hsin https://orcid.org/0009-0001-1508-5276
Herrero, Javier https://orcid.org/0000-0001-7313-717X
Wu, Yin https://orcid.org/0000-0003-4080-3935
Moore, David A. https://orcid.org/0000-0002-6296-1312
Karasaki, Takahiro https://orcid.org/0000-0001-6863-2360
Grigoriadis, Kristiana https://orcid.org/0000-0002-8435-0176
Lu, Wei-Ting https://orcid.org/0000-0002-1405-4806
Veeriah, Selvaraju
Naceur-Lombardelli, Cristina https://orcid.org/0000-0002-7097-0307
Magno, Neil
Ward, Sophia https://orcid.org/0000-0002-6777-5279
Frankell, Alexander M. https://orcid.org/0000-0002-0341-7878
Hill, Mark S. https://orcid.org/0000-0003-0718-8934
Colliver, Emma https://orcid.org/0000-0002-1497-0740
de Carné Trécesson, Sophie https://orcid.org/0000-0002-9341-2586
East, Philip https://orcid.org/0000-0001-5801-5713
Malhi, Aman
Snell, Daniel M.
O’Neill, Olga
Leonce, Daniel
Mattsson, Johanna
Lindberg, Amanda https://orcid.org/0000-0001-8206-5294
Micke, Patrick
Moldvay, Judit
Megyesfalvi, Zsolt
Dome, Balazs
Fillinger, János
Nicod, Jerome https://orcid.org/0000-0003-2459-3480
Downward, Julian https://orcid.org/0000-0002-2331-4729
Szallasi, Zoltan https://orcid.org/0000-0001-5395-7509
,
Huebner, Ariana
Richard, Corentin
Hiley, Crispin T.
Lim, Emilia L.
Gimeno-Valiente, Francisco
Thakkar, Krupa
Bakir, Maise Al
Sivakumar, Monica
Usaite, Ieva
Saghafinia, Sadegh
Vanloo, Sharon
Harries, Sian
Toncheva, Antonia
Prymas, Paulina
Mussa, Bushra
Magala, Michalina
Keene, Elizabeth
Bunkum, Abigail
Martínez-Ruiz, Carlos
Puttick, Clare
Karagianni, Despoina
Black, James R. M.
Thol, Kerstin
McGranahan, Nicholas
Lucas, Olivia
Bentham, Robert
Vendramin, Roberto
Quezada, Sergio A.
Zaccaria, Simone
Hessey, Sonya
Bola, Supreet Kaur
Liu, Wing Kin
Zaidi, Rija
Patruno, Lucrezia
Forster, Martin D.
Lee, Siow Ming
Wilson, Gareth A.
Rosenthal, Rachel
Rowan, Andrew
Bailey, Chris
Lee, Claudia
Enfield, Katey S. S.
Angelova, Mihaela
Pich, Oriol
Murphy, Cian
Zagorulya, Maria
Leung, Michelle M.
Marafioti, Teresa
Borg, Elaine
Falzon, Mary
Khiroya, Reena
Jones, Thomas Patrick
Benafif, Sarah
Papadatos-Pastos, Dionysis
Wilson, James
Ahmad, Tanya
Dwornik, Angela
Karamani, Angeliki
Chain, Benny
Pearce, David R.
Stavrou, Georgia
Mastrokalos, Gerasimos-Theodoros
Lowe, Helen L.
Reading, James L.
Hartley, John A.
Selvaraju, Kayalvizhi
Ensell, Leah
Shah, Mansi
Litovchenko, Maria
Pawlik, Piotr
Gamble, Samuel
Ung, Seng Kuong Anakin
Spanswick, Victoria
Weeden, Clare E.
Grönroos, Eva
Goldman, Jacki
Escudero, Mickael
Hobson, Philip
Boeing, Stefan
Denner, Tamara
Barbè, Vittorio
Hill, William
Naito, Yutaka
Sahai, Erik
Ramsden, Zoe
Kassiotis, George
Noorani, Imran
Lester, Jason F.
Bajaj, Amrita
Nakas, Apostolos
Sodha-Ramdeen, Azmina
Tufail, Mohamad
Scotland, Molly
Boyles, Rebecca
Rathinam, Sridhar
Dulloo, Sean
Fennell, Dean A.
Wilson, Claire
Matharu, Gurdeep
Shaw, Jacqui A.
Boleti, Ekaterini
Cheyne, Heather
Khalil, Mohammed
Richardson, Shirley
Cruickshank, Tracey
Price, Gillian
Kerr, Keith M.
French, Jack
Gilbert, Kayleigh
Naidu, Babu
Patel, Akshay J.
Osman, Aya
Sangha, Mandeesh
Langman, Gerald
Shackleford, Helen
Djearaman, Madava
Middleton, Gary
Leek, Angela
Hodgkinson, Jack Davies
Totton, Nicola
Fontaine, Eustace
Granato, Felice
Novasio, Juliette
Rammohan, Kendadai
Joseph, Leena
Bishop, Paul
Joshi, Vijay
Waplington, Sara
Atkin, Adam
Paiva-Correia, Antonio
Crosbie, Philip
Brown, Katherine D.
Carter, Mathew
Chaturvedi, Anshuman
Oliveira, Pedro
Lindsay, Colin R.
Blackhall, Fiona H.
Summers, Yvonne
Krebs, Matthew G.
Tugwood, Jonathan
Dive, Caroline
Aerts, Hugo J. W. L.
Schwarz, Roland F.
Kaufmann, Tom L.
Van Loo, Peter
Castignani, Carla
Salgado, Roberto
Diossy, Miklos
Demeulemeester, Jonas
Beck, Stephan
Nye, Emma
Stone, Richard Kevin
Rane, Jayant K.
Kittel, Jeanette
Haase, Kerstin
Koh, Kexin
Scott, Rachel
Peggs, Karl S.
Hoogenboom, Emilie Martinoni
Monk, Fleur
Holding, James W.
Choudhary, Junaid
Bhakhri, Kunal
Gorman, Pat
Stephens, Robert C. M.
Wong, Yien Ning Sophia
Pisciella, Maria Chiara
Bandula, Steve
Watkins, Thomas B. K.
Veiga, Catarina
Royle, Gary
Collins-Fekete, Charles-Antoine
Fraioli, Francesco
Ashford, Paul
Procter, Alexander James
Ahmed, Asia
Taylor, Magali N.
Nair, Arjun
Lawrence, David
Patrini, Davide
Navani, Neal
Thakrar, Ricky M.
Janes, Sam M.
Kaplar, Zoltan
Hackshaw, Allan
Pilotti, Camilla
Leslie, Rachel
Hacker, Anne-Marie
Smith, Sean
Walker, Aoife
Grapa, Anca
Zhang, Hanyun
AbdulJabbar, Khalid
Pan, Xiaoxi
Yuan, Yinyin
Chuter, David
MacKenzie, Mairead
Chee, Serena
Georg, Patricia
Alzetani, Aiman
Cave, Judith
Lim, Eric
De Sousa, Paulo
Jordan, Simon
Rice, Alexandra
Raubenheimer, Hilgardt
Bhayani, Harshil
Ambrose, Lyn
Devaraj, Anand
Chavan, Hemangi
Begum, Sofina
Buderi, Silviu I.
Kaniu, Daniel
Malima, Mpho
Booth, Sarah
Nicholson, Andrew G.
Fernandes, Nadia
Shah, Pratibha
Proli, Chiara
Hewish, Madeleine
Danson, Sarah
Shackcloth, Michael J.
Robinson, Lily
Russell, Peter
Blyth, Kevin G.
Kidd, Andrew
Dick, Craig
Le Quesne, John
Kirk, Alan
Asif, Mo
Bilancia, Rocco
Kostoulas, Nikos
Whiteley, Jennifer
Thomas, Mathew
Hackshaw, Allan https://orcid.org/0000-0002-5570-5070
Jamal-Hanjani, Mariam https://orcid.org/0000-0003-1212-1259
Kanu, Nnennaya https://orcid.org/0000-0001-7232-1952
Birkbak, Nicolai J. https://orcid.org/0000-0003-1613-9587
Swanton, Charles https://orcid.org/0000-0002-4299-3018
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 15 November 2024
First Online: 9 January 2025
Competing interests
: D.B. reports personal fees from NanoString and AstraZeneca and has a patent PCT/GB2020/050221 issued on methods for cancer prognostication. Y.W. consults for E15 VC and Prokarium. D.A.M. reports speaker fees from AstraZeneca, Eli Lilly, BMS and Takeda, consultancy fees from AstraZeneca, Thermo Fisher, Takeda, Amgen, Janssen, MIM Software, Bristol Myers Squibb and Eli Lilly and has received educational support from Takeda and Amgen. S.C.T. has acted as a consultant for Revolution Medicines. J.D. has acted as a consultant for AstraZeneca, Jubilant, Theras, Roche and Vividion and has funded research agreements with Bristol Myers Squibb, Revolution Medicines, Novartis, Vividion and AstraZeneca. M.J.-H. has consulted for Astex Pharmaceutical and Achilles Therapeutics, and is a member of, the Achilles Therapeutics Scientific Advisory Board and Steering Committee, has received speaker honoraria from Pfizer, Astex Pharmaceuticals, Oslo Cancer Cluster, Bristol Myers Squibb and Genentech. M.J.-H. is listed as a co-inventor on a European patent application relating to methods to detect lung cancer PCT/US2017/028013), this patent has been licensed to commercial entities and, under terms of employment, M.J.-H. is due a share of any revenue generated from such license(s), and is also listed as a co-inventor on the GB priority patent application (GB2400424.4) with title: Treatment and Prevention of Lung Cancer. N.J.B. is listed as a co-inventor on a patent to identify responders to cancer treatment (PCT/GB2018/051912), has a patent application (PCT/GB2020/050221) on methods for cancer prognostication and a patent on methods for predicting anti-cancer response (US14/466,208). C.S. acknowledges grant support from AstraZeneca, Boehringer-Ingelheim, BMS, Pfizer, Roche-Ventana, Invitae (previously Archer Dx (collaboration in minimal residual disease sequencing technologies)) and Ono Pharmaceutical. C.S. is an AstraZeneca Advisory Board member and Chief Investigator for the AZ MeRmaiD 1 and 2 clinical trials and is also Co-Chief Investigator of the NHS Galleri trial funded by GRAIL and a paid member of GRAIL’s SAB. He receives consultant fees from Achilles Therapeutics (also a SAB member), Bicycle Therapeutics (also a SAB member), Genentech, Medicxi, Roche Innovation Centre–Shanghai, Metabomed (until July 2022), and the Sarah Cannon Research Institute. C.S. had stock options in Apogen Biotechnologies and GRAIL until June 2021, currently has stock options in Epic Bioscience and Bicycle Therapeutics and has stock options and is co-founder of Achilles Therapeutics. C.S. is an inventor on a European patent application relating to an assay technology to detect tumor recurrence (PCT/ GB2017/053289), the patent has been licensed to commercial entities and under his terms of employment, C.S. is due a revenue share of any revenue generated from such license(s). C.S. holds patents relating to targeting neoantigens (PCT/EP2016/059401), identifying patient responses to immune checkpoint blockade (PCT/EP2016/071471), determining HLA LOH (PCT/ GB2018/052004), predicting survival rates of patients with cancer (PCT/GB2020/050221), identifying patients who respond to cancer treatment (PCT/GB2018/051912), a US patent relating to detecting tumor mutations (PCT/US2017/28013), methods for lung cancer detection (US20190106751A1) and both a European and US patent related to identifying indel mutation targets (PCT/GB2018/051892) and is a co-inventor on a patent application to determine methods and systems for tumor monitoring (PCT/EP2022/077987). C.S. is a named inventor on a provisional patent related to a ctDNA detection algorithm. The other authors declare no competing interests.
